Delivery Order SPE2DB24D3013-SPE2DB24FFHSZ

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,649.55 and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,065.64, is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of March 12, 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.08, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through May 23, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has a ceiling value of $10,815.93 and is structured as a firm fixed price delivery order, with a period of performance through May 23, 2025. The contract is not designated as a set-aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,740.46, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at...
This is a $4,705.06 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a performance period through May 2, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,338.50, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract with a completion date of January 30, 2025. This award is not associated with a set-aside designation. In addition to this specific delivery order,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,634.00, is for the supply of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. The contract has a completion date of March 13, 2025 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,784.85, is for the delivery of Fluticasone Prop HFA 110 MCG 12GM, a prescription medication. The contract has a firm fixed price pricing type and a period of performance through February 20, 2024. This delivery order is issued under AmerisourceBergen's...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,379.49, is for the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHSZ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $3,116.59, is for the supply of the pharmaceutical product Fluticasone Prop HFA 44 MCG 10.6GM. The contract has an ultimate completion date of September 12, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/11/24, 9:28 AM